
United States · Research startup
OccamzRazor is a digital biotech company based in New York City, dedicated to discovering and developing treatments for complex brain-aging diseases, particularly Parkinson’s disease.
Funding reportedLast round: Series A
OccamzRazor is a digital biotech company based in New York City, dedicated to discovering and developing treatments for complex brain-aging diseases, particularly Parkinson’s disease.
Founded in 2015, the company focuses on creating curative therapies for neurodegenerative conditions through its advanced drug discovery platform. The company utilizes machine learning and digital science, employing techniques such as graph machine learning, graph prediction, and natural language processing. This approach helps map scientific knowledge, generate hypotheses, identify biomarkers, and discover therapeutic targets. OccamzRazor's proprietary technologies include RazorBrainTM, RazorLinkTM, RazorPanoramaTM, and Panoramic AI, which support its preclinical development efforts.
Funding, as reported
What they build
Known for
health carepreclinical therapiesbiotechnology researchdata sciencegraph machine learningneurodegenerative diseasesbrain disease mechanismsbiomedical literature mininginformation technology & servicesartificial intelligence computational drug discoveryneuroinformaticsinformation technologyhospital & health caremedicalgraph predictionprotein-protein interactions
Built with from their website
WordPress.orgGoogle CloudGoogle WorkspaceViewport MetaGoogle Cloud HostingGoogle MeetPriority HintsMySQLMobile FriendlyOpen Graph
RSSSquarespaceWordpressHSTSGoogle Cloud DNSPHPSquarespace CommerceAdobe Fonts
Add your raise, your deck and your story, and put OccamzRazor in front of investors. Or tell us what we have wrong.